Intrepid Financial Planning Group’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-3,435
Closed -$103K 132
2024
Q3
$103K Hold
3,435
0.04% 120
2024
Q2
$90.2K Hold
3,435
0.04% 120
2024
Q1
$98K Hold
3,435
0.04% 121
2023
Q4
$104K Hold
3,435
0.05% 115
2023
Q3
$94.6K Sell
3,435
-230
-6% -$7.37K 0.05% 113
2023
Q2
$128K Sell
3,665
-32
-0.9% -$1.11K 0.06% 114
2023
Q1
$130K Sell
3,697
-161
-4% -$5.78K 0.07% 112
2022
Q4
$134K Sell
3,858
-260
-6% -$9.15K 0.07% 105
2022
Q3
$140K Sell
4,118
-312
-7% -$11.6K 0.08% 97
2022
Q2
$153K Buy
+4,430
New +$165K 0.08% 96

Other funds holding HEAL

Intrepid Financial Planning Group's HEAL Position: Q4 2024 in Review

Intrepid Financial Planning Group sold out of Global X Funds Global X HealthTech ETF (HEAL) in Q4 2024, closing a stake of 3,435 shares — an estimated $103K sold.

Intrepid Financial Planning Group first reported a position in HEAL in Q2 2022 and held it in 10 quarters. The position peaked at $153K in Q2 2022. 28 funds tracked by Wall St. Rank hold HEAL as of Q4 2024.

  • Intrepid Financial Planning Group reported no remaining Global X Funds Global X HealthTech ETF position as of Q4 2024 after selling out during the quarter.
  • Intrepid Financial Planning Group sold 3,435 Global X Funds Global X HealthTech ETF shares in Q4 2024, an estimated $103K.
  • Intrepid Financial Planning Group first reported a position in Global X Funds Global X HealthTech ETF in Q2 2022 and held it in 10 quarters.
  • Intrepid Financial Planning Group's Global X Funds Global X HealthTech ETF position peaked at $153K in Q2 2022.
  • 28 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q4 2024.

Based on Intrepid Financial Planning Group's 13F filing for Q4 2024, filed 10 Feb 2025.